AFP and hepatocellular carcinoma: It is possible that the natural history of HCC in this patient population that largely has HBV-related HCC may be more favorable.54 Along with early stage of disease (BCLC stage 0 or A) and receipt of curative treatment, low AFP level (<20 ng/mL) was associated with higher survival in this HCC cohort.